Expectation of radionuclide analgesic therapy in patients with metastatic carcinoma of bone

The characteristic of several common radioactive analgesics are compared. Also a greatly expected new drug, ¹⁸⁸Re-HEDP is introduced for its superior radio-physical and radio-chemical property. At last, advice is given about the national-wide evaluating standard of radionuclide analgesic therapy of osteocopic pain.